devinitorg/iati-policy-markers huggingface dataset:
Health Policy and Systems Research to inform emergency preparedness in fragile, conflict-affected and vulnerable (FCV) settings A collaboration between the World Health Organization (WHO) Alliance for Health Policy and Systems Research (AHPSR) and the National Institute for Health and Care Research (NIHR) to support a call for Health Policy and Systems research that systematically examines how and why fragile, conflict-affected, and vulnerable (FCV) settings have (or have not) been able to manage previous emergencies. Convene national stakeholders (particularly in the Eastern Mediterranean and African regions) to identify Health Policy and Systems Research (HPSR) priorities around emergency preparedness and inform the development of a framework specific to emergency preparedness in fragile, conflict-affected and vulnerable (FCV) settings; 
Support the development of HPSR led by researchers and practitioners based in selected FCV settings to respond to the identified priorities and support national emergency preparedness efforts - to this end the research programme will specifically identify and support FCV settings where there are existing/envisaged processes to strengthen the emergency preparedness architecture;  
Draw cross-national and cross-regional learning to inform regional and global emergency preparedness efforts; and  
Strengthen capacities of selected FCV setting-based researchers and practitioners in the conduct and dissemination of HPSR.
NIHR Global Health Research Unit on Neglected Tropical Diseases A UK and low- and middle-income country (LMIC) partnership that aims to improve diagnosis, prevention, response and treatment of podoconiosis, mycetoma and scabies. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. 1) To improve the ability to diagnose, prevent and treat podoconiosis. 2) To develop tools to prevent mycetoma - there is no effective treatment. 3) To strengthen the ability of low-income countries to respond to scabies outbreaks.
WHO Alliance for Health Policy and Systems Research Partnership The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR works in partnership with the Alliance for Health Policy and Systems Research (AHPSR), a hosted partnership of the World Health Organization (WHO), to fund the generation and use of health policy and systems research as a means to strengthen the health systems of Low and Middle-Income Countries (LMICs). Stimulate the generation and synthesis of policy-relevant health systems knowledge, encompassing evidence, tools and methods; 
Promote the dissemination and use of health policy and systems knowledge to improve the performance of health systems; and
Facilitate the development of capacity for the generation, dissemination and use of HPSR knowledge among researchers, policy-makers and other stakeholders.
Medicines for Malaria Venture The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided support to the Medicines for Malaria Venture (MMV) to carry out activities relating to the development of new drugs to treat malaria. 1) Increase investment in chemoprevention; 2) Develop new fast acting molecules to support treatment of uncomplicated and potentially severe malaria; 3) Develop compounds active against laboratory generated resistant strains and field isolates.
NIHR-MRC Global Maternal and Neonatal Health Call 1 (2019) The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). This programme is administered by the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to MRC, which makes onwards disbursements to awardees. The purpose of the call is to address the burden of maternal and neonatal mortality and morbidity in low and middle income countries (LMICs), by funding high-quality proposals across the spectrum of basic to applied research The first call focuses on the period of pregnancy and birth where the highest risks are faced and where the triple burden of maternal death, neonatal death and stillbirth is heaviest.
Awards support multidisciplinary approaches, build and strengthen research partnerships, and promote capacity building in global maternal and neonatal health research.
NIHR Global Health Research Groups: research call 2 The NIHR's second Global Health Research call for Groups. UK universities and research institutes were invited to submit applications, working in equitable partnerships with researchers in low- and middle-income countries (LMIC), to develop their ambitions to deliver world-class applied global health research to address under-funded or under-researched global health areas specific to those countries. 1) Deliver the UK's ambition to be internationally outstanding in global health research, improving the lives of people in LMIC. 2) Create an environment where world-class global health research, focused on the needs of LMIC can thrive. 3) Translate advances in applied global health research into benefits for patients and the public in LMIC. 4) Focus on priority areas which will have the greatest impact on health in LMIC in the short, medium and long term. 5) Provide high quality research evidence to inform decision-making by public health officials, practitioners and policy makers. 6) Increase the volume and quality of multi-disciplinary global health research from the UK. 7) Develop knowledge and capacity within existing UK institutions which can be translated into global health research practice.
NIHR RIGHT 4: Drowning prevention for newly mobile infants under 2 years in Bangladesh A UK and low- and middle-income country (LMIC) research partnership to prevent drowning young children aged 1-2 in Bangladesh. The project is a collaboration between Bournemouth University, the Royal National Lifeboat Institute (RNLI), the University of the West of England, the University of Southampton (all in the UK), and the Center for Injury Prevention & Research Bangladesh. Using an inclusive, humancentred design approach to identify the solutions that are most acceptable to local communities, whose input will be central to the whole process. Our interdisciplinary project aims to reduce the incidence of drowning in young children in the north and south of Bangladesh. The objectives of the project are; 1. Build skills needed by communities and our research partners in rural
Bangladesh, focusing on research capacity building around both public involvement in research and Human-Centred Design. 2. Explore existing supervision practice for newly mobile children and the social, cultural and environmental circumstances in which drowning occurs. Using social science research methods will help understand the failures of existing interventions (if any) and challenges of keeping young children safe from drowning; 3. Identify possible solutions to the prevention of drowning from literature and our explorative social science study. Engage stakeholders (including local community, government officials, designers, social scientists, drowning prevention experts, our international advisory group) to help prioritise a range of possible solutions; 4. Develop and create new solutions, using Human-Centred-Design principles and processes, co-designed with people in the local community; 5. Test the best solutions from the Human-Centred Design process in communities and evaluate them on use and maintenance, effectiveness, and ability to roll out the interventions across Bangladesh; 6. Share the findings and lessons learnt both locally with the communities involved in the research, nationally in Bangladesh with policy-makers and relevant civil servants, and internationally through academic papers and at conferences.
NIHR Global Health Research Group on Asthma Attacks Causes and Prevention Study in Urban Latin America A UK and low- and middle-income country (LMIC) partnership that aims to study causes of and test a strategy to prevent asthma attacks in Latin America, focussing on underserved urban settings in Brazil and Ecuador, with high levels of inequality. 1) Set up a Global Health Research Group at St George’s in collaboration with key partners in Brazil, Ecuador, and the UK. 2) Deliver a programme of implementation and epidemiological research through prevention of severe asthma attacks among adults in Brazil and asthma attacks in children and adolescents in Ecuador, and identification of risk factors associated with asthma attacks and recurrence of asthma attacks. 3) Establish collaborative links with LMIC partners by strengthening existing links with Brazilian and Ecuadorian partners, establishing new links with academic institutions in Ecuador involved in asthma research and control and establishing new/ strengthening existing links with key stakeholders including Ministries of Public Health, municipal departments of health, national respiratory societies, other NGOs and patient groups in Ecuador and Brazil. 4) Develop research capacity through short to extended periods of research training and exchanges between Brazil and Ecuador. Short exchanges will be funded through this programme while extended periods will be funded through alternative sources within Brazil and Ecuador.
NIHR Global Health Research Group on Prevention and Management of Non-Communicable Diseases and HIV-infection in Africa A UK and low- and middle-income country (LMIC) partnership that aims to evaluate integrated prevention and management of chronic conditions in Africa, focusing on the double burden of HIV-infection with diabetes and hypertension, and on research that is relevant for policy and practice. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. 1) To develop a partnership between the Liverpool School of Tropical Medicine (LSTM), African researchers in Uganda and Tanzania, health policy makers and programme managers, patient groups and community representatives and engage with other stakeholders to conduct research that has maximum immediate benefit on patient outcomes in Africa. 2) To develop and strengthen capacity in NCDs and in research methods, particularly in epidemiology, statistics, health economics and social science, both at LSTM and at our partner institutions in Africa. These skills are severely lacking and inhibiting research in chronic diseases. 3) To conduct early phase (pilot) studies and assess how diagnostic and treatment services for HIVinfection, diabetes and hypertension should be integrated at health facilities, how these integrated services should be decentralised, how task-shifting should be organised and how patients should be supported and monitored.
NIHR HPSR-DA: Re_Emerge: Research to accelerate progress on emergency preparedness and universal health coverage in four Ebola-affected countries Equitable access to healthcare is a key element of emergency preparedness. However, in low-income countries, efforts to strengthen preparedness tend to be disconnected from actions to achieve universal health coverage (UHC). We aim to provide decision-makers with the evidence they need to pursue preparedness and equity goals in synergy. By establishing the Re_Emerge consortium, we aim to produce the evidence needed by key stakeholders working in disease outbreak-affected low-income countries (LIC), so that they can align their efforts, and advance preparedness and UHC through integrated governance and synergistic decision-making. The consortium will conduct research in four low-income countries (LICs) - Sierra Leone, Liberia, Guinea and the Democratic Republic of Congo (DRC) - which recently experienced (and, in DRC’s case, is currently experiencing) outbreaks of Ebola Virus Disease (EVD). We intend to use the development grant to lay the groundwork for this by consolidating an emerging multi-partner collaboration on achieving integrated approaches to health systems strengthening in Ebola-affected settings – led by the University of Edinburgh (UK) and the College of Medicine and Allied Health Sciences (Sierra Leone). 1) Establish arrangements for consortium governance 
2) Set up an advisory board of key stakeholders
3) Define capacity needs of our partners
4) Conduct a synthesis of existing data to establish strategic priorities and key evidence needs
5) Construct an initial theory of change, setting out pathways from evidence needs to real-world impact
6) Draft and publish academic/policy outputs from the synthesis
7) Establish plans for a competitive funding application to the NIHR.
NIHR Global Health Research Programme Enhancements: Results Framework development for NIHR Global Health Research Units and Groups Technical assistance for a Monitoring and Evaluation expert to develop a results framework for the Global Health Research Units and Groups Programme To develop a Monitoring and Evaluation framework for the Global Health Research Units and Groups programme. There are 53 Units and Groups being funded and there is a need to track performance and delivery against a common set of indicators to allow an assessment of how this meets overarching GHR Programme objectives as set out in the Theory of Change, and to measure what impact this programme has had.
NIHR RIGHT3: The CONTROL programme - Cognitive therapy for depression in tuberculosis treatment. A UK and low-and-middle-income-country (LMIC) research partnership that aims to improve outcomes for depression and tuberculosis (TB) in Pakistan, Afghanistan, and the Afghan refugee population in Pakistan.
Tuberculosis (TB) is the 10th leading cause of death in the world. Pakistan ranks fifth and fourth in the world for having a high-burden of TB and MultiDrug Resistant Tuberculosis (MDR-TB), respectively. Afghanistan has an even worse TB situation due to ongoing conflict.
It is estimated that almost 49% of people receiving TB treatment may also have depression. Depression may be caused as a result of TB related stigma or the side effects of TB treatments. When these conditions co-exist they may raise the risk of TB reactivation, contribute to poor adherence to TB treatment and disease progression. Inadequate treatment adherence often results in drug resistant TB (MDR-TB), potentially leading to a public health crisis and health security threat.
Through four linked work packages the project team aims to develop, test and implement a brief intervention: CONTROL (Cognitive therapy for depression in tuberculosis treatment) to improve the mental health and adherence to TB treatment in people who have TB and MDR-TB in Pakistan and Afghanistan, and the refugee Afghan population in Pakistan. The cognitive therapy for depression in tuberculosis treatment (CONTROL) programme of research has five objectives:
1. To develop, and pilot test the CONTROL intervention with patient and public involvement and engagement (PPIE).
2. To evaluate the effectiveness and cost-effectiveness of CONTROL versus Enhanced Treatment As Usual (ETAU) in improving depressive symptoms in people with TB and depression (TBD) and also enhance adherence with anti TB treatment (ATT).
3. To examine the effects of implementing CONTROL on the TB control programme and the wider health system.
4. To complete a process evaluation, refine the intervention, to identify barriers and facilitators for implementation and examine how the intervention can be scaled up in the health system.
5. To enhance capacity for implementation research in multimorbidity associated with chronic infections in the region.
Global Patient Safety Collaborative The main objective of the Global Patient Safety Collaborative (GPSC) is to secure and scale up global action on patient safety as well as to work in close collaboration with selected low- and middle-income countries (LMICs) in their quest to reduce the risk of avoidable harm and improve the safety of their national health care systems. 1) Strengthen leadership to promote patient safety across all sectors and settings; 2) Develop a competent workforce through education and training in patient safety; and 3) Support research capacities and evidence-based policies, strategies and standards.
NIHR Global Health Research Group: The Shire Valley Vector Control Project (Shire-Vec) The Shire Valley Vector Control Project (Shire-Vec) will address the balance between food security and infectious disease in expanding irrigated land in southern Malawi. 

The goal of Shire-Vec is to reduce the burden of endemic vector-borne diseases (VBDs) while maintaining or improving equitable economic benefits for smallholder farming communities. 

We will focus our research on a new 40,000-hectare irrigation scheme in southern Malawi; the Shire Valley Transformation programme (SVTP). 

Construction on the SVTP began in 2020 and will continue throughout the decade. This provides a real-time natural longitudinal experiment to determine 
i.	the impact of land-use transformation on vector-borne diseases
ii.	how local smallholder farming practices will change on the ground and how this influences risk of vector-borne infection
iii.	practical solutions for integration across both public health and agriculture
Our primary diseases of interest are malaria and schistosomiasis due to the unequivocal link between irrigation and their host-vector life cycle, but we include provisions to look at the impact on emerging VBDs such as arboviruses. Objectives: 
1.	Strengthen vector-borne disease surveillance and research capacity between the agriculture and public health sector. 

We will bring together stakeholders from across public health and agriculture via the Technical Vector Control Advisory Group of the Ministry of Health in Malawi. 

We will achieve real impact by engaging with local farming communities of the lower Shire Valley via a dedicated Community Engagement and Involvement team and the establishment of a Community Advisory Group. 

Finally, a cohort of pre- and post-doctoral Malawian trainees will be recruited and integrated into Shire-Vec to strengthen the future capacity of vector-borne disease research and control in Malawi.

2.	Determine the risk of vector-borne disease inside and outside of the irrigation catchment area. 
We will conduct insect vector and epidemiological surveillance in selected sentinel sites around irrigated farms. 

Ethnographic research will study behavioural practices in the farming communities and the influence on vector-host contact. 
3.	Pilot locally tailored interventions which tackle either single or multiple vectors, determine their acceptability to the community and establish their value for money.
4.	Integrate vector control into agricultural and irrigation policy, using the evidence generated through Shire-Vec to provide recommendations for mitigating vector-borne disease in future planned extensions of the SVTP beyond 2025 and other national agricultural development schemes.
Proposal and Partnership Development Awards (PPDA) for NIHR Research and Innovation for Global Health Transformation (RIGHT) call 6 Stage 2 applicants The purpose of Proposal and Partnership Development Awards (PPDA) funding is to improve the quality and likelihood of success of the projects funded through the NIHR Research and Innovation for Global Health Transformation (RIGHT) programme. Applicants that are successful at RIGHT Stage 1 and invited to submit a Stage 2 application are eligible for a PPDA, subject to satisfactory submission of a PPDA application. Not all Stage 2 applicants awarded a PPDA go on to secure RIGHT programme funding. For RIGHT Call 6, PPDA were extended to 12 applicant organisations to support partnership development and the preparation of a RIGHT Stage 2 application. Proposal and Partnership Development Awards (PPDA) provide funding of up to £10,000 for organisations applying to NIHR Research and Innovation for Global Health Transformation (RIGHT) programme funding to:
1.	Support applicants to work collaboratively with all study partners to develop the stage 2 application
2.	Enhance partnerships across the proposed research collaboration
3.	Initiate preparation of study governance documentation (i.e. due diligence and finance assurance policies)
PPDA funds must be spent between the notification of RIGHT stage 1 outcome and the submission of the RIGHT stage 2 application.
NIHR Global Health Research Group on the Application of Genomics and Modelling to the Control of Virus Pathogens (GeMVi) in East Africa A UK and low- and middle-income country (LMIC) partnership that aims to redress the imbalance of understanding, community spread and optimal control of infection diseases in East Africa. 1) Create a sustainable collaborative network of institutes (UK and East Africa) that collectively support applied virus epidemiological research and provide an evidence base for decision making by public health authorities in East Africa. 2) Provide training and research support for a cohort of 20 quantitative East African scientists to develop advanced skills in viral genomics and predictive modelling. This will enable them to address locally defined problems and input into country-specific recommendations. 3) Establish and transfer genome sequencing methods (eg compact real-time Nanopore technology) with associated analysis steps (or pipelines) for virus Next Generation Sequence (NGS) data, and construct mathematical models to predict the impact of different intervention options.  Outputs will be open source resources for combining sequence and epidemiological data analysis with transmission dynamic modelling. 4) Develop the Zeeman Institute at the University of Warwick as a centre of expertise for integrated mathematical and genomic epidemiology, with meaningful ties to East African Institutes. 5) Establish an East African Alliance for Virus Prevention and Control Preparedness (VPCP) with the aim of coordinating research-evidenced responses to public health needs.

Following a costed extension, additional objectives will include:
Work Package 1: Enhance public health virus surveillance and research through cost-effective next generation sequencing (NGS) capacity in public health laboratories across the East African Region.
1. Use of the low-cost portable Oxford Nanopore Technology NGS platform MinION in Low and Middle Income Country laboratories to allow pathogen whole genome sequencing.

Work Package 2: Strengthen the role of mathematical modelling in providing evidence for public health decision making.
1. Establish greater modelling capacity at KWTRP, Nairobi by linking health systems and economics teams with university departments and relevant Ministry of Health departments.
NIHR satellite session at the 15th Internation Health Economics Association (IHEA) World Congress on Health Economics To inform the development of a dedicated NIHR-led health economics programme and activities, NIHR is undertaking outreach and consultation activities to establish areas where there is an unmet need or skill shortage and areas which are under-funded or under-researched. The 15th International Health Economics Association (IHEA) World Congress on Health Economics presented a unique opportunity for NIHR to engage in an international event and consult stakeholders on key methodologies, impactful policy research and  capacity strenghtening  through the organisation of a dedicated satellite session. 1. Raise the profile of NIHR in the global health research funding landscape
2. Bring together researchers and thought-leaders to inform the development of the NIHR Global Health Research programme’s future activities in health economics
3. Provide support to the participation of low-and-middle-income country (LMIC) based speakers in the Symposium